CHRNA7 and diabetes mellitus: Activation of the α7 nAChR expressed on resident macrophages may suppress the local inflammation by reducing the production of pro-inflammatory cytokines TNF and IL-6 [17], [18], which are closely associated with some inflammatory diseases, including sepsis, rheumatoid arthritis, asthma, and diabetes [19]–[21].